Glucotrack (GCTK) Research & Development (2010 - 2025)
Glucotrack's (GCTK) quarterly Research & Development came in at $1.6 million in Q4 2025, down 4.24% YoY from $1.7 million in Q4 2024, and down 48.59% on a QoQ basis from $3.2 million in Q3 2025.
Glucotrack (GCTK) Research & Development (2010 - 2025) Analysis & Trends
Glucotrack (GCTK) has 15 years of Research & Development data on file, last reported at $1.6 million in Q4 2025.
- Quarterly Research & Development fell 4.24% year-over-year to $1.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $8.1 million (down 15.04% YoY) and the FY2025 annual result came in at $9.8 million, up 3.31% from the prior year.
- Research & Development eased to $1.6 million in Q4 2025, from $3.2 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $3.6 million in Q2 2024 to a low of -$2.8 million in Q4 2023.
- A 5-year average of $1.0 million and a median of $615500.0 in 2022 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2022 — Research & Development surged 20033.33% — and 2023, when it slumped 568.71%.
- Tracing GCTK's Research & Development over 5 years: stood at $3000.0 in 2021, then surged by 20033.33% to $604000.0 in 2022, then tumbled by 568.71% to -$2.8 million in 2023, then jumped by 160.01% to $1.7 million in 2024, then dropped by 4.24% to $1.6 million in 2025.
- The last three Research & Development figures came in at $1.6 million (Q4 2025), $3.2 million (Q3 2025), and $3.2 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 370.60 Mn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 258.00 Mn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 663.00 Mn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 105.73 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 19.70 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 178.00 Mn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 42.50 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 129.00 Mn |
| 10 | Glucotrack | 1.73 Mn | 607,139.82 | - | 2.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.63 Mn |
| Sep 30, 2025 | 3.17 Mn |
| Jun 30, 2025 | 3.15 Mn |
| Mar 31, 2025 | 128,000.00 |
| Dec 31, 2024 | 1.70 Mn |
| Sep 30, 2024 | 2.06 Mn |
| Jun 30, 2024 | 3.59 Mn |
| Mar 31, 2024 | 2.15 Mn |
| Dec 31, 2023 | -2.83 Mn |
| Sep 30, 2023 | 1.69 Mn |
| Jun 30, 2023 | 627,000.00 |
| Mar 31, 2023 | 642,000.00 |
| Dec 31, 2022 | 604,000.00 |
| Sep 30, 2022 | 434,000.00 |
| Jun 30, 2022 | 469,000.00 |
| Mar 31, 2022 | 460,000.00 |
| Dec 31, 2021 | 3,000.00 |
| Sep 30, 2021 | 113,000.00 |
| Jun 30, 2021 | 321,000.00 |
| Mar 31, 2021 | 309,000.00 |